Jennifer K Plichta

Jennifer K Plichta

Duke University

H-index: 23

North America-United States

About Jennifer K Plichta

Jennifer K Plichta, With an exceptional h-index of 23 and a recent h-index of 22 (since 2020), a distinguished researcher at Duke University, specializes in the field of breast surgery, breast cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer?

Digital Health Platforms for Breast Cancer Care: A Scoping Review

Paget's disease of the breast: Insights from imaging to guide surgical management

Survival among patients with untreated metastatic breast cancer:“What if I do nothing?”

Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy

Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy

Axillary nodal disease burden is not associated with an elevated 21-gene recurrence score in post-menopausal women presenting with a clinically negative axilla

The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease

Jennifer K Plichta Information

University

Position

Associate Professor

Citations(all)

3118

Citations(since 2020)

2374

Cited By

1424

hIndex(all)

23

hIndex(since 2020)

22

i10Index(all)

54

i10Index(since 2020)

52

Email

University Profile Page

Google Scholar

Jennifer K Plichta Skills & Research Interests

breast surgery

breast cancer

Top articles of Jennifer K Plichta

Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer?

Journal of Surgical Research

2024/4/1

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Digital Health Platforms for Breast Cancer Care: A Scoping Review

2024/3/27

Samantha Kaplan
Samantha Kaplan

H-Index: 5

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Paget's disease of the breast: Insights from imaging to guide surgical management

2024/3/18

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Survival among patients with untreated metastatic breast cancer:“What if I do nothing?”

2021/5/20

Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy

Annals of Surgical Treatment and Research

2020/6/1

Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy

Journal of Clinical Oncology

2024/2/23

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Axillary nodal disease burden is not associated with an elevated 21-gene recurrence score in post-menopausal women presenting with a clinically negative axilla

The American Journal of Surgery

2024/2/6

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease

JAMA surgery

2024/2/1

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Implementation of a novel peer review academy by Surgery and the Association of Women Surgeons

Surgery

2024/2/1

Karuna Dewan
Karuna Dewan

H-Index: 5

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis

Breast Cancer Research and Treatment

2024/2

Abstract PO4-17-11: Normalized Breast Cancer Survival Outcomes in US Tumor Registries

Cancer Research

2024/5/2

Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks

2024/1/23

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

Journal of Clinical Oncology

2024/1/4

BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits

The American Journal of Surgery

2024/1/1

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Abstract PO4-18-01: International Validation of a Staging Model for de novo Metastatic Breast Cancer

Cancer Research

2024/5/2

Abstract PO3-05-13: A Multi-Institutional Review of Contralateral Axillary Metastases: Time for Reclassification as Local-Regional Event?

Cancer Research

2024/5/2

Abstract PO1-10-01: Racial/Ethnic Disparities in Rates of Pathological Complete Response and Survival in Patients with Inflammatory Breast Cancer

Cancer Research

2024/5/2

Breast cancer risk assessment and screening practices reported via an online survey

Annals of Surgical Oncology

2023/10

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

The role of tumor phenotype in the surgical treatment of early-stage breast cancer

The American Journal of Surgery

2023/1/1

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board

The oncologist

2023/1/1

Jie He
Jie He

H-Index: 12

Jennifer K Plichta
Jennifer K Plichta

H-Index: 17

See List of Professors in Jennifer K Plichta University(Duke University)

Co-Authors

academic-engine